The University of Glasgow Develops Compelling Cancer Test to Help Boost Clinical Trials Participation

The University of Glasgow Develops Compelling Cancer Test to Help Boost Clinical Trials Participation

The University of Glasgow, Scotland has developed a cancer test to improve research into the disease and boost the number of participants in clinical trials. The new trials include a suite of affordable solid tumor and blood cancer tests designed to be used in the routine healthcare worldwide. The Glasgow-based team hopes that it will help scientists in their effort to discover what makes cancer resistant to chemotherapy drugs.

The lead investigator is professor Andrew Biankin, a regius professor of surgery at the University of Glasgow and director of the Glasgow Precision Oncology Laboratory (GPOL), said “The Glasgow Cancer Tests were created so that ultimately every patient could have access to the latest treatments and clinical trials.

Lead Research/Investigator

Andrew Biankin, a regius professor of surgery at the University of Glasgow and director of the Glasgow Precision Oncology Laboratory (GPOL)

Call to Action: Interested in learning more? Are you based in the Glasgow area? Follow the link to Professor Biankin. 
...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee